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Epiphyseal impaction as a cause of severe osteoarticular pain of lower
limbs after renal transplantation. A syndrome of severe osteoarticular
pain of lower limbs occurring early after renal transplantation (TP) has
been recently identified. We describe its prevalence, clinical presenta-
tion and outcome. Symptomatic patients have been studied with
conventional X-rays, magnetic resonance (MR) imaging, and ssmTech
netium scintigrams of the painful areas. Among 86 patients transplanted
over a two-year period, nine (4 men, 5 women; mean age of 40.4 years;
range 32 to 59) developed unexplained severe spontaneous osteoartic-
ular pain of lower limbs 19 to 105 (mean 58) days after TP. Pain affected
hip(s), knee(s), and/or ankle(s). Clinical examination was usually unre-
markable. Favorable outcome was the rule; mean duration of pain was
86 (range 19 to 175) days. Radiographs were abnormal (joint swelling,
patchy osteoporosis and/or periosteal reactions) in 41%, MR (epiphy-
seal fatty marrow replacement by edema and/or hemorrhages) in 83%,
and bone scans (one to several epiphyseal foci of increased uptake) in
81% of the symptomatic examined areas. Among joints re-examined 9
to 12 months after resolution of the symptoms, X-rays showed perios-
teal reactions in 31%, and the bone scans disclosed persistent increased
uptake in 53% of the joints, whereas epiphyseal MR abnormalities had
completely disappeared in 86%. There was no difference in dialysis
duration, post-TP weight gain, evidence of hyperparathyroidism, and
steroid and cyclosporine doses between symptomatic and an appropri-
ately selected group of asymptomatic patients. By contrast, serum
alkaline phosphatase levels were transiently higher (at the onset of
symptoms) in the symptomatic group. Clinical presentation and Out-
come, imaging findings (mainly MR), and transient elevation in alkaline
phosphatase levels suggest a diagnosis of epiphyseal impaction as the
basis of this syndrome. Cyclosporine and steroids, both osteopenic
agents, might have predisposed to impaction. As their dosage was not
higher than in an asymptomatic control group, it is suggested that an
additional factor such as excessive physical exercise in the post-TP
period may play a role.
The frequency of post-transplantation avascular bone necro-
sis [1, 2] has fallen dramatically as dosage of steroids was
reduced with the advent of cyclosporine. Recently, a syndrome
of transient severe osteoarticular pain, localized mainly in
lower limbs, has been recognized [3—10], but its incidence and
physiopathology are yet to be delineated. In this paper, we
review its clinical presentation in nine patients and describe its
characteristics on conventional radiographs, bone scan and
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magnetic resonance (MR) imaging. We propose that this syn-
drome might result from epiphyseal impaction.
Methods
Patients
Eighty-six kidney recipients transplanted between June 1989
and June 1991 and followed exclusively in our outpatient clinic
were evaluated for osteoarticular pain of upper or lower limbs.
Patients with pain due to gout, pseudo-gout, cytomegalovirus
(CMV) or septic arthritis, and tendinopathy were excluded. We
eventually identified nine patients with unexplained osteoartic-
ular pain localized in their lower limbs. These patients were
followed up to February 1992.
Immunosuppressive treatment consisted of antilymphocyte
globulin (50 mg/kg/day for 1 day, 25 mg/kg/day for 14 days),
cyclosporin A (8 to 10 mg/kg/day initially, gradually tapered to
an average of 4 mg/kg/day within 6 months), azathioprine (1 to
1.5 mg/kg/day) and prednisolone (25 mg/day gradually tapered
to 15 mg/day after 2 months, to 12.5 mg/day 1 month later, to 10
mg/day 6 months after transplantation and to 7.5 mg/day
between 9 months and 1 year after transplantation). Acute
rejections were treated by intravenous methylprednisolone (500
mg/day for three days), together with antithymocyte globulin (4
mg/kg/day) or OKT3 (Orthoclone'; 5 mg/day) for 10 days.
Investigations
Serum calcium, phosphate, uric acid, alkaline phosphatase
and parathyroid hormones (PTH) levels (non-commercial radio-
immunoassay which determined the C-terminal portion of the
enzyme; NV: 15 to 65 pg/ml), as well as a 24-hour urinary
excretion of calcium and phosphate were measured, both at the
time of transplantation (TP) and at the onset of the symptom-
atology. These investigations were repeated subsequently
throughout the symptomatic and the subsequent asymptomatic
period. Cyclosporine trough levels were measured in the serum
by fluorescence-polarization immunoassay (non-specific poly-
clonal antibody, Abbott) after two hours of equilibration of the
blood sample at room temperature. Kidney function tests
(blood urea and serum creatinine levels) were measured at each
outpatient clinic visit.
Radiographs of hips and hands were routinely obtained
immediately after TP. Conventional radiographs of symptom-
atic joints were performed within two weeks after the onset of
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Table 1. Distribution of pain in symptomatic patients (N = 9)
Ankle Knee Hip
Unilateral 2 0 3
Bilateral 3 7 1
Total joints 8 14 5
symptoms. A whole body static scintigram with 99 methylene
Technetium (99mTC) diphosphonate (Medronate) was obtained
within an average of 23 days (range 6 to 42) after onset of
symptoms. Areas of focal or diffuse increased activity within
the lower limbs were tabulated. MR imaging of the painful areas
was performed in all but one claustrophobic patient within six
weeks after onset of symptoms. MR investigations included
Ti-weighted images obtained with the appropriate coils on a
superconducting magnet (Gyroscan, 1.5 TESLA, Philips Med-
ical System, The Netherlands) by using repetition time (TR) of
4.5 msec and echo time (TE) of 20 msec in all clinically affected
joints, and T2-weighted images of at least one affected joint per
patient by using TR of 2000 msec and TE of 80 msec.
Control group
Laboratory data of the nine symptomatic patients, their
steroid doses, and cyclosporine doses and trough levels, were
compared with those of 16 kidney graft recipients retrospec-
tively matched for age, sex, date and rank of transplantation.
We obtained one matching for each of the two patients trans-
planted for the second time and two matchings for the others.
Clinical and biological data obtained at onset of symptoms in
the symptomatic group were compared with those obtained
after an equivalent post-TP delay in the control group. Hip and
hand radiographs obtained immediately after TP were also
compared in both groups. Statistical differences were analyzed
by the appropriate unpaired Student's t-test.
Investigations after resolution of the symptoms
Nine to twelve months after resolution of symptoms, radio-
logic and radionucleide investigations were repeated in eight
patients (16 and 17 symptomatic joints, respectively) and MR
studies in four patients (9 symptomatic joints).
Investigations of asymptomatic patients
After completion of our study, eight successive asymptom-
atic kidney recipients (6 men and 2 women; mean age 42.4
years, range 21 to 63) underwent a total body scintigram and an
MR study of their knees and ankles (Ti-weighted images)
within three months after TP.
Results
Clinical data
Out of the 86 transplanted patients at risk, nine (5 women, 4
men; 10%) spontaneously reported a continuous, incapacitating
osteoarticular pain of their lower limb joints. Pain occurred 58
days (range 19 to 105) after TP, involving 27 joints of the lower
limbs only, mainly the ankles and knees (Table 1). Symmetrical
joints were involved in eight patients.
The symptoms shared the following characteristics: (1) they
always resulted in some degree of functional impairment; (2)
they increased at night (patients awakened by pain); (3) and
they had never occurred prior to TP. Difficulty in walking,
reported by all patients, led to the use of crutches in four and a
wheel-chair in one.
The patients had a mean age of 40.4 (range 32 to 59) years and
had been dialyzed during an average of 32.4 12.4 (range 0 to
123) months. Four patients had a history of steroid therapy
(previous failed graft in 2 and treatment of primary renal disease
in the 2 others). Three patients had also been given pulses of
steroids for episode(s) of acute rejection(s) (Table 2).
Clinical examination of the affected area was usually unre-
markable; periarticular soft tissue swelling and joint hypersen-
sitivity were reported in three and four symptomatic joints,
respectively, out of the 27. Skin erythema similar to that
accompanying reflex sympathetic dystrophy was not observed.
Little relief was obtained with antiinflammatory drugs or anal-
gesics. One patient received calcitonin (100 IU subcutaneously!
day during 3 months) without any benefit. In three patients,
pain appeared in the knees while symptoms were subsiding in
the ankles.
Pain resolved after 86 days on the average (range 19 to 175) in
all but patient 8, who has still some pain in two out of five joints
one year after the onset of symptoms.
Comparison with the control group
As shown in Table 3 there was no difference in dialysis
duration, post-TP weight gain, mean number of acute rejection
episodes, renal function, evidence of hyperparathyroidism (se-
rum PTH, calcium and phosphate, 24-hr urinary calcium and
phosphate excretion) or serum uric acid levels between symp-
tomatic and control patients. By contrast, serum alkaline phos-
phatase levels were higher at the onset of symptoms in the
symptomatic group, although they were virtually identical at
the time of TP (Fig. 1).
Immunosuppression therapy was virtually identical in both
groups three weeks before the symptoms, at their onset and
after their resolution (Table 4).
Radiological signs of active hyperparathyroidism as evalu-
ated by bone resorption in phalanges were observed in two
symptomatic and one control patients.
Initial imaging investigations
Standard radiographs were abnormal in ii of 27 (4 1%)
affected joints (Table 5). Patchy osteoporosis of the epiphyseal
cancelious bone was visible in eight symptomatic joints. Focal
osteoporosis tended to predominate in the subchondral areas.
Its extent and severity were quite variable. Joint spaces were
preserved. Effusions were detected within three joints. Metaph-
yseal periosteal reactions were also noted in three cases. Bone
scan disclosed a total of 54 foci of increased uptake in 22 out of
27 affected joints (81%). Patterns of involvement varied from
localized (ito 4 per joint) foci (Fig. 3) to a more diffuse uptake
in the whole joint.
MR imaging was obtained in 23 symptomatic joints (8 pa-
tients). Sagittal images of ankles and knees were obtained while
coronal views were performed for the hips. In 19 of them (83%),
the epiphyseal bone marrow contained one or several ill-defined
foci of low intensity signal on Ti-weighted images with corre-
sponding high intensity on T2-weighted images. These foci were
predominantly localized in subchondral bone areas. Several
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Table 2. Clinical characteristics of the symptomatic patients
Patient
number Age Sex Original nephropathy
Dialysis
duration
months
Pre-TP
cortico-
therapy
Number of
acute rejection
episodes
1 32 F Wegener's granulomatosis 28 (+) 0
2 39 M CGN 8 (—) 0
3 59 M IgA nephropathy 39 (—) 0
4 40 F Unknown 39 (+)a 0
5 30 M CPN 0 (—) 0
6 41 F Type II MP GN 123 (—) 1
7 40 M CGN 0 (+) 4
8 33 F CPM 29 (—) I
9 50 F Unknown 50 (+)a 0
Abbreviations are: CGN, chronic glomerulonephritis unspecified type; CPN, chronic pyelonephritis; MP GN, membranoproliferative
glomerulonephritis.
a Previous renal transplantation
Table 3. Clinical and biological data (mean sEM) at the onset of symptoms as compared to controls
Symptomatic
patients (N = 9)
Controls(N = 16) P
Clinical
Dialysis duration months 32.4 12.4 38.1 9.1 NS
Weight gain after TP kg 3.02 1.62 2.48 0.56 NS
No. of acute rejection/patient 0.66 1.32 0.31 0.12 NS
Biological
Serum calcium (NV:8.8—l0.4 mg/dl) 10.31 0.20 10.40 0.12 NS
phosphate (NV:2.4—4.4 mg/dl) 1.89 0.25 2.12 0.18 NS
PTH (NV: 15—65 pg/mI) 156.6 45.05 266.2 52.6 NS
Alk phosph (NV:10—60 lU/liter) 87.22 14.16 54.93 4.56 0.013
uric acid (NV:3—7 mg/dl) 4.99 0.64 5.7 0.30 NS
creatinine (NV:0.8—l.3 mg/dl) 1.51 0.32 1.50 0.17 NS
urea (NV:15—50 mgldl) 50.82 12.38 55.11 5.4 NS
24 Hour calciuria mg 138.7 22.4 149.1 26.5 NS
phosphaturia mg 1054 195.1 761.4 65.7 NS
contained bands of lower intensity on both Ti and T2-weighted
images (Fig. 2 a and b). In patient 2, a similar area of low signal
intensity appeared in the metaphyseal region of one knee
together with ischemic epiphyseal lesions (that is, normal
marrow signal area circumscribed by a low signal intensity rim
on Ti-weighted images). In three symptomatic patients, MR
imaging was also obtained in five asymptomatic joints (2 knees,
3 ankles). Interestingly, in one patient both knees showed a
focus of low signal intensity on Ti-weighted images.
Long-term evolution and investigations after resolution of the
symptoms
Immunosuppressive regimen was not modified except that
prednisolone dose was reduced according to the treatment
protocol. Cyclosporine dose remained virtually unchanged (5 to
4.6 mg/kg/day) throughout the symptomatic period.
Among the eight patients in whom symptoms had subsided,
no recurrence was noted in six (14 to 29 months follow-up),
whereas in the two others (patients 2 and 7) a previously
symptomatic hip became painful 3 and 12 months later, respec-
tively.
On follow-up radiographs (Table 6), joint effusion and can-
cellous bone rarefaction had disappeared in four initially abnor-
mal joints. Solid periosteal appositions were visible in the
juxta-articular areas of five (31%) joints. The two hips in which
pain recurred showed a femoral head collapse typical for
epiphyseal osteonecrosis.
On follow-up bone scintigraphy (17 previously abnormal
joints), abnormalities had disappeared in eight joints (Fig. 4),
whereas the nine others (53%) had a persistent, although
apparently reduced uptake. In patient 2 the hip in which the
femoral head eventually collapsed was initially normal, but on
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Fig. 1. Alkaline phosphatase levels (and SEM) in symptomatic patients(-•-, N = 9), as compared with controls (-0-, N = 16), at both the time
of the transplantation and at the onset of symptoms. P = 0.013.
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Table 4. Immunosuppressive therapy
Symptomatic patients Controls
Prednisolone
Cyclosporine
Prednisolone
Cyclosporine
trough levelstrough levels
mg/day ng/ml mg/kg/day mg/day ng/ml mg/kg/day
3 Weeks before 21.5 3.74 42.89 13.75 5.69 2.27 19.53 3.19 41.21 14.46 6.83 2.25
symptoms
At onset of 17.06 1.99 49.44 25.33 4.91 1.84 17.03 2.24 40.06 2.24 6.20 2.13
symptoms
At the end of 13.87 2.49 36.75 9.78 4.66 1.33 14.29 3.46 32.62 13.02 4.90 1.12
symptoms
Table 5. Initial imaging of symptomatic joints
Abnormal radiographs Abnormal
magnetic
patchy b periosteal Abnormal bone resonancea
osteoporosis reactions scana (N = 27) (N = 23)
Ankles (8) 1 3 6 6/6
Knees (14) 6 0 12 11/12
Hips (5) 1 0 4 2/5
Total (27) 11(41%) 22 (81%) 19 (83%)
See text for details about findings of abnormal bone scan and MR
b Note that effusions were detected in three joints with patchy
osteoporosis
follow-up intense uptake developed. Follow-up bone scan was
not available for the second hip with collapse (patient 7); it was
also initially normal.
MR images obtained in seven previously abnormal joints (4
patients) showed complete resolution of the focal marrow
changes (Fig. 2c) except in patient 2 in whom residual marrow
abnormalities were still observed in one previously ischemic
knee.
Alkaline phosphatase levels were repeatedly determined in
some patients. They peaked at the end of the symptomatology
and returned to normal within six months (data not shown).
Investigations in asymptomatic patients
Among the eight asymptomatic patients, bone scan disclosed
four foci of abnormal uptake within three joints (1 ankle and 2
knees) of two patients. Tl-weighted imaging showed an ill-
defined focus of low signal intensity in two joints (1 ankle, 1
knee) of two patients and a focus of normal intensity sur-
rounded by a rim of low signal in both knees of a third patient.
All joints with a positive bone scan had abnormal MR images.
Discussion
Our data show that 10% of patients given a renal transplant
develop within the first six months after TP a syndrome of
transient, severe musculoskeletal pain of the lower limbs,
mainly knees and ankles. Symptoms, often bilateral, impair
walking ability in all patients. They are increased by activity,
partially relieved by rest and sometimes worsened during the
night. Clinical examination of the affected area is usually
unremarkable except for occasional periarticular soft tissue
swelling and local tenderness at palpation.
A similar clinical syndrome, with analogous radiologic and
isotopic findings, has been recently reported by other groups
Table 6. Follow-up imaging of symptomatic joints
Abnormal radiographs(N = 16)
periosteal reactions
Abnormal bone
scan(N = 17)
Abnormal MR
(N = 7)
Ankles 1 3 0
Knees 4 6 1b
Hips 08 o8 08
Total 5 (3 1%) 9 (53%) 1(14%)
Imaging results of reinvestigated joints 9 to 12 months after the
symptomatology had subsided.
a Note that in two symptomatic hips the three imaging techniques
disclosed abnormalities. Recurrence of pain was associated with the
development of femoral head collapse (2 hips) and signs of femoral head
collapse on bone scan and MR (only one reinvestigated hip). See text.
b Patient 2 had residual marrow abnormalities in one previously
ischemic area in one knee.
[3—7, 10]. Just as in our patients, the delay between transplan-
tation and onset of symptoms ranged between one and five
months. Symptoms lasted from a few weeks to several months
and even two years in a few cases [6]. Symptoms completely
subsided in all but one patient. Interestingly, a few patients
reported symptoms not only in the lower limbs but also in the
shoulders and/or the wrists [4, 6, 7, 10].
In the three largest series [4, 5, 7] involving a total of 40
patients, standard radiographs disclosed spotty or diffuse bone
osteoporosis in 42.5% of the patients and scintigraphy demon-
strated an abnormal uptake in 87.5% of the subjects. Our results
expressed as a percentage of patients with a significant abnor-
mality are similar (41% and 81%, respectively). Unfortunately
these studies provide little information per symptomatic joint.
Magnetic resonance studies were performed in only three cases
[4, 7]; in two of them low-signal intensity areas within the
marrow spaces on Ti-weighted images were mentioned without
further detail. The reported prevalence of the syndrome varies
from 2.9 [5] to 14.5% [7], values similar to ours (10%).
The cause of this syndrome is yet to be elucidated. In our
patients, gout, pseudo-gout, CMV or septic arthritis, or tendi-
nopathy, had been excluded on clinical, biological and radio-
logical grounds. Sympathetic reflex dystrophy syndrome sug-
gested by others [4, 5] seems also unlikely since none of our
patients exhibited typical skin erythema; moreover, the multi-
plicity of involved joints argues against that diagnosis. We
propose that this syndrome is due to epiphyseal impaction.
This hypothesis fits with the clinical presentation and the
spontaneously favorable evolution. It is mainly supported by
the MR findings. The presence of ill-defined focal areas of
tj1
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Fig. 2. A. Initial sagittal TI-weighted MR
image through the lateral compartment of the
left knee (patient 4). The proximal tibial
epiphysis shows a normal MR marrow signal.
The posterior third of the femoral condyle
marrow shows a reduced signal intensity.
Note predominant signal changes in the
subchondral area and the presence of small
subchondral bands of low signal intensity
(white arrows). B. Corresponding T2-weighted
MR image shows a high signal intensity area
in the marrow spaces which appeared as a
low signal intensity on A. C. Follow-up
sagittal TI-weighted identical MR plane. It
demonstrates complete resolution of the initial
marrow changes.
low-signal intensity on Ti-weighted images which become
brighter on T2-weighted pictures are consistent with edema,
and/or hemorrhages within the bone medullary spaces. Identi-
cal abnormalities have been reported in cases of stress fractures
[11—13], insufficiency fractures [121 and in radiographically
occult post-traumatic lesions of the knees [14, 15]. Moreover,
the presence, within these areas, of linear bands of low-signal
intensity on both Ti and T2 weighted images are consistent with
an impaction within cancellous bone [14—17]. The predomi-
nance of such lesions in subchondral areas would be unex-
pected in neoplastic or infectious lesions. The complete long-
term resolution of the MR abnormalities is also consistent with
occult fractures [12—141.
The increased uptake of the radiotracer in the corresponding
areas of MR abnormalities, although non-specific, is also com-
patible with impactions [13, 14] as it reflects an augmented
blood flow and/or an increased osteoblastic activity in the
damaged area [18, 19]; the slow resolution of the scintigraphic
abnormalities is probably related to the duration of the bone
remodeling process [19].
Although non-specific and very subtle, the X-ray findings of
subchondral bone rarefactions and subsequent periosteal reac-
tions, are also compatible with the development and repair of
epiphyseal impactions [20].
The elevated level of serum alkaline phosphatase at the onset
of symptoms fits with a transient increase in ósteoblastic
activity associated with impactions.
It is of note that, although rare, the MR abnormalities may be
'I
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Fig. 2. Continued.
found in asymptomatic joints. Indeed, they were identified
together with an abnormal bone scan in four out of 32investi-
gated ankles and knees of asymptomatic patients and in an
additional two asymptomatic joints of the nine symptomatic
patients. These findings suggest that the prevalence of impac-
tion may be higher than that recorded on the basis of painful
joints.
If epiphyseal impaction accounts for the transient joint pain
observed after renal TP, what is its cause? Cyclosporine has
been incriminated [3—5, 7]. Lucas et al note that the onset of
symptoms coincides in their patients with the introduction of
cyclosporine in the immunosuppressive treatment [7, 10],
whereas Munoz-Gomez et a! emphasize that cyclosporine is the
only immunosuppressive agent in the majority of their patients
[5]. Cyclosporine could indeed be a risk factor as it induces an
osteoclastic hyperactivity both in humans and in rats [21—23].
However, it cannot be the only etiological factor for several
reasons. An identical symptomatology has been described in
kidney recipients who were not given cyclosporine [6, 24, 25].
Furthermore, contrary to Lucas' observations [7, 10], the
symptomatology subsided in our patients despite the mainte-
nance of a virtually unchanged cyclosporine dosage.
Steroids, which have a well-recognized osteopenic effect,
enhance trabecular bone resorption [1, 26]. Together with
cyclosporine they could predispose bone structures to impac-
tions. It is noteworthy that cyclosporine and steroid dosages
were virtually identical in both symptomatic and control
groups. In addition there was no obvious temporal relationship
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Fig. 2. Continued.
between the rejection treatment and onset of symptoms. Other
potential contributory factors such as dialysis duration, para-
thyroid overactivity and post-transplant weight gain did not
differ among the two groups.
The absence of clearly identified risk factors suggests an
individual susceptibility. It is known that osteopenia predis-
poses to mechanically induced impaction [27, 281. Unfortu-
nately, it was not possible in our retrospective study to assess
physical activities in the early post-transplant period and to
compare it in the symptomatic and asymptomatic groups. Still,
a significant role of exercise could account for both the multi-
plicity of the affected joints and their preferential location in the
weight bearing joints of the lower limbs [12, 13].
We suggest that bone impaction induces "a stormy reaction"
within the epiphyseal bone medulla with vasodilatation and
subsequent osteoblastic hyperactivity. Acutely, it is usually,
though not always, symptomatic and occasionally provokes
skin vasodilatation mimicking sympathetic reflex dystrophy. If
repair activities exceed destruction, healing ensues. Some-
times, however, repair is deficient and impaction progresses to
epiphyseal collapse. Within this framework we now advise our
recently transplanted patients to refrain from excessive physi-
cal activity. Symptomatic patients should rest since, in stress
fractures prolonged exercise leads to impaction of the same
bone of the opposite limb, or another bone of the same limb
[20].
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Fig. 3. Initial bone scan image of both knees
in the same patient (4) demonstrates multiple
foci of increased uptake within epiphyseal
areas (R = right).
Fig. 4. Follow-up bone scan image of the
same patient demonstrates a normalization of
the radionucleide uptake in the epiphyseal
areas (R = right).
In conclusion, we describe a syndrome of transient arthral- References
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